Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Shares of T2 Biosystems Are Falling Friday


Shares of T2 Biosystems (NASDAQ: TT00) were down more than 46% as of 10:45 a.m. on Friday after the healthcare company announced preliminary third-quarter earnings and a reverse stock split on Thursday. The stock is down more than 93% this year.

T2 Biosystems is a diagnostics company that focuses on detecting sepsis-causing pathogens and antibiotic resistance genes. On Thursday, the company said it expected third-quarter revenue of $1.5 million, down 60% year over year, blaming the drop mainly on a $1 million reduction in Biomedical Advanced Research and Development Authority revenue. 

T2 also said it expects full-year revenue of $7.5 million, down 10% compared to last year because of a sepsis test panel backorder.

Continue reading


Source Fool.com

Like: 0
Share

Comments